hovid Report issue

For profit Phase 2 Phase 3
Founded: Perak Malaysia (1980)

Organization Overview

First Clinical Trial
2020
NCT04658823
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Hovid Berhad

Active Ingredients

Drugs in Phase 3 Trials (1)

ivermectin (stromectol) (1 trial)

Drugs in Phase 2 Trials (2)

tocotrienol (3 trials)

vitamin e (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

CADASIL (Phase 2)

Dementia, Multi-Infarct (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 4
  • # of Trial APIs: 3